Company Profiles

driven by the PitchBook Platform

Innovent Biologics

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

2011

Founded

PRIVATE

Status

201-500

Employees

Series D

Latest Deal Type

$260M

Latest Deal Amount

$385M

Total Amount Raised

Description

Operator of a bio-pharmaceutical company that develops monoclonal antibody products. The company's pipeline focuses on oncology, autoimmune disorders, cardiovascular diseases, inflammatory diseases and ophthalmology.

Website:

www.innoventbio.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

168 Dongping Street Suzhou Industrial Park Suzhou, Jiangsu 215123China +86 (0)512 6956 6088
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Innovent Biologics's full profile, request a free trial.

    Innovent Biologics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Innovent Biologics Investors (12)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    China Life Private EquityOtherMinority000 0000000 0000
    Eight Roads VenturesVenture CapitalMinority000 0000000 0000
    F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
    Frontline BioVenturesVenture CapitalMinority000 0000000 0000
    Hillhouse Capital GroupVenture CapitalMinority000 0000000 0000
    China Life Private Equity Other
    Eight Roads Ventures Venture Capital
    F-Prime Capital Partners Venture Capital
    Frontline BioVentures Venture Capital
    Hillhouse Capital Group Venture Capital

    Innovent Biologics Executive Team (15)

    NameTitleBoard
    Seat
    Contact
    Info
    Michael Yu Ph.DCo-founder, Chairman, President & Chief Executive Officer
    Qinwei Zhou Ph.DChief Operating Officer
    Shao XuefengFinancial Controller
    Xiaolin LiuSenior Vice President, Research & Development
    Junjian LiuVice President, Biologics Discovery
    Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer
    Qinwei Zhou Ph.D Chief Operating Officer
    Shao Xuefeng Financial Controller
    Xiaolin Liu Senior Vice President, Research & Development
    Junjian Liu Vice President, Biologics Discovery

    Innovent Biologics Board Members (13)

    NameRepresentingRoleSinceContact
    Info
    Charles Cooney Ph.DSelfBoard Member000 0000
    Daniel AuerbachBoard Member000 0000
    Daqing Cai Ph.DLegend CapitalManaging Director000 0000
    Leon ChenSelfBoard Member000 0000
    Michael Yu Ph.DInnovent BiologicsCo-founder, Chairman, President & Chief Executive Officer000 0000
    Charles Cooney Ph.D Board Member Self
    Daniel Auerbach Board Member
    Daqing Cai Ph.D Managing Director Legend Capital
    Leon Chen Board Member Self
    Michael Yu Ph.D Co-founder, Chairman, President & Chief Executive Officer Innovent Biologics
    Request full access to PitchBook